A longtime veteran of the pharma industry is leading a $4 billion expansion in Johnston County. In a year full of big ...

Excavators at the future Novo Nordisk expansion site in Clayton, NC hoist up U.S., Denmark, and North Carolina flags on June 24, 2024. Brian Gordon bgordon@newsobserver Boviet Solar, 908 jobs ...

Excavators at the future Novo Nordisk expansion site in Clayton, NC hoist up U.S., Denmark, and North Carolina flags on June 24, 2024. Boviet Solar, 908 jobs Setting a fast timeline, the ...

EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived ...

Both Eli Lilly and Novo Nordisk have invested in GLP-1 injectables manufacturing sites, with more capacity on the way. With a ribbon-cutting ceremony and tour on June 14, 2024, Lilly showed off its ...

And while the 540 extension is making it easier to commute, the county is also hoping to build on companies like Novo Nordisk and Grifols setting up shop right at home. "So it's my role is to grow ...

Since the 1990s, Novo Nordisk has operated a facility in Clayton, where it makes injectable finished products like insulin pens to treat diabetes. In the past few years however, the company has ...

IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

It hasn't been a great period for investors in Novo Nordisk (NYSE: NVO) despite its ongoing status as one of the pharmaceutical industry's apex competitors in the field of cardiometabolic drugs.